Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Heroin Dependence, Opioid-Related Disorders

In brief

The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependent volunteers.

Key facts

Study ID

NCT00000331

Run by

University of Colorado, Denver

People needed

0

Starts

2002-12-01

Expected to finish

2002-12-01

Last updated by the study team

2017-05-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals must be healthy, non-drug dependent volunteers, be at least 18 years of age, and have no prior history of drug or alcohol abuse or dependence. Subjects must have had some minimal experience with opioids (e.g. at least two prior exposures)

You may not qualify if…

• Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.

Where it is running

• University of Colorado Health Sciences Center — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.